John Pløen

1.7k total citations · 1 hit paper
34 papers, 1.2k citations indexed

About

John Pløen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Pløen has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Pløen's work include Colorectal Cancer Surgical Treatments (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Colorectal and Anal Carcinomas (10 papers). John Pløen is often cited by papers focused on Colorectal Cancer Surgical Treatments (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Colorectal and Anal Carcinomas (10 papers). John Pløen collaborates with scholars based in Denmark, United States and Sweden. John Pløen's co-authors include Anders Jakobsen, Jan Lindebjerg, Ane Appelt, Søren Rafael Rafaelsen, Lars Henrik Jensen, Jens Christian Riis Jørgensen, Søren M. Bentzen, Ivan R. Vogelius, Henrik Harling and Frank Svendsen Jensen and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

John Pløen

33 papers receiving 1.2k citations

Hit Papers

High-dose chemoradiotherapy and watchful waiting for dist... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
    2015 367 citations Ane Appelt, John Pløen et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Pløen Denmark 15 1.0k 728 282 230 146 34 1.2k
Minghuan Li China 17 368 0.4× 280 0.4× 494 1.8× 216 0.9× 136 0.9× 46 912
Laura M. Fernández Brazil 22 967 1.0× 766 1.1× 285 1.0× 192 0.8× 28 0.2× 62 1.2k
Michitaka Nagase Japan 18 640 0.6× 666 0.9× 836 3.0× 64 0.3× 53 0.4× 51 1.3k
Suzana Stojanović-Rundić Serbia 10 563 0.6× 483 0.7× 185 0.7× 148 0.6× 75 0.5× 48 797
Florence Castan France 13 516 0.5× 313 0.4× 213 0.8× 108 0.5× 36 0.2× 36 710
Robert A. Rostock United States 14 256 0.3× 270 0.4× 193 0.7× 192 0.8× 150 1.0× 26 695
Maria Fenton-Kerimian United States 11 471 0.5× 108 0.1× 200 0.7× 190 0.8× 210 1.4× 26 855
Eva Holtved Denmark 9 652 0.6× 621 0.9× 495 1.8× 73 0.3× 58 0.4× 19 1.0k
Thomas O’Rourke Australia 6 649 0.6× 431 0.6× 245 0.9× 61 0.3× 30 0.2× 9 904
Paola Rosetti Italy 9 792 0.8× 592 0.8× 183 0.6× 51 0.2× 28 0.2× 17 893

Countries citing papers authored by John Pløen

Since Specialization
Citations

This map shows the geographic impact of John Pløen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pløen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pløen more than expected).

Fields of papers citing papers by John Pløen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Pløen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pløen. The network helps show where John Pløen may publish in the future.

Co-authorship network of co-authors of John Pløen

This figure shows the co-authorship network connecting the top 25 collaborators of John Pløen. A scholar is included among the top collaborators of John Pløen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Pløen. John Pløen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hansen, Torben Frøstrup, Eva Fernebro, John Pløen, et al.. (2021). Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations. International Journal of Cancer. 149(1). 119–126. 10 indexed citations
2.
Pløen, John, Stine K. Frandsen, Søren Rafael Rafaelsen, et al.. (2021). Study protocol designed to investigate tumour response to calcium electroporation in cancers affecting the skin: a non-randomised phase II clinical trial. BMJ Open. 11(6). e046779–e046779. 14 indexed citations
3.
Hansen, Torben Frøstrup, John Pløen, Lars Henrik Jensen, et al.. (2019). Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 106(3). 556–563. 29 indexed citations
4.
Jakobsen, Anders, Anders Fischer, Lars Henrik Jensen, et al.. (2015). Neoadjuvant chemotherapy in locally advanced colon cancer.A phase II trial. Acta Oncologica. 54(10). 1747–1753. 88 indexed citations
5.
Appelt, Ane, John Pløen, Henrik Harling, et al.. (2015). High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. The Lancet Oncology. 16(8). 919–927. 367 indexed citations breakdown →
6.
Rafaelsen, Søren Rafael, et al.. (2015). Elastography and diffusion-weighted MRI in patients with rectal cancer. British Journal of Radiology. 88(1056). 20150294–20150294. 8 indexed citations
7.
Appelt, Ane, et al.. (2014). MRI-guided brachytherapy for rectal cancer: A treatment planning study with a shieldable multicatheter applicator. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
8.
Appelt, Ane, Ivan R. Vogelius, John Pløen, et al.. (2014). Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost. International Journal of Radiation Oncology*Biology*Physics. 90(1). 110–118. 37 indexed citations
9.
Pløen, John, et al.. (2014). PO-1041: MRI-guided brachytherapy for rectal cancer: A treatment planning study with a shieldable multicatheter applicator. Radiotherapy and Oncology. 111. S160–S160. 1 indexed citations
10.
Spindler, Karen‐Lise Garm, Morten Mau‐Sørensen, Niels Pallisgaard, et al.. (2013). Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma. Acta Oncologica. 52(5). 963–970. 46 indexed citations
11.
Nørgaard, A., Claus Dam, Anders Jakobsen, et al.. (2013). Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan. Scandinavian Journal of Gastroenterology. 49(2). 202–208. 43 indexed citations
12.
Rafaelsen, Søren Rafael, et al.. (2013). Ultrasound elastography in patients with rectal cancer treated with chemoradiation. European Journal of Radiology. 82(6). 913–917. 26 indexed citations
13.
Jensen, Lars Henrik, Jan Lindebjerg, John Pløen, Torben Frøstrup Hansen, & Anders Jakobsen. (2012). Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Annals of Oncology. 23(9). 2341–2346. 75 indexed citations
14.
Havelund, Birgitte Mayland, Paw Christian Holdgaard, Søren Rafael Rafaelsen, et al.. (2012). Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer. Nuclear Medicine Communications. 34(2). 155–161. 31 indexed citations
15.
Appelt, Ane, John Pløen, Ivan R. Vogelius, Søren M. Bentzen, & Anders Jakobsen. (2012). Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 85(1). 74–80. 188 indexed citations
16.
Jakobsen, Anders, John Pløen, T. Vuong, et al.. (2012). Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer: A Randomized Trial Comparing Two Radiation Doses. International Journal of Radiation Oncology*Biology*Physics. 84(4). 949–954. 75 indexed citations
17.
Lindebjerg, Jan, et al.. (2011). Factors influencing reproducibility of tumour regression grading after high-dose chemoradiation of locally advanced rectal cancer. Histopathology. 59(1). 18–21. 14 indexed citations
18.
Spindler, K.-L.G., Rikke Fredslund Andersen, Lars Henrik Jensen, John Pløen, & Anders Jakobsen. (2009). EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer. Annals of Oncology. 21(3). 535–539. 24 indexed citations
19.
Lindebjerg, Jan, K.-L.G. Spindler, John Pløen, & Anders Jakobsen. (2008). The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long‐course preoperative chemoradiotherapy. Colorectal Disease. 11(3). 264–269. 39 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghuan Li Breakdown of academic impact, for papers by Laura M. Fernández Breakdown of academic impact, for papers by Michitaka Nagase Breakdown of academic impact, for papers by Suzana Stojanović-Rundić Breakdown of academic impact, for papers by Florence Castan Breakdown of academic impact, for papers by Robert A. Rostock Breakdown of academic impact, for papers by Maria Fenton-Kerimian Breakdown of academic impact, for papers by Eva Holtved Breakdown of academic impact, for papers by Thomas O’Rourke Breakdown of academic impact, for papers by Paola Rosetti
Rankless by CCL
2026